Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | NEU1 | Q99519 | 9/20 | 0.36 |
| ▸ | NEU4 | Q8WWR8 | 6/20 | 0.36 |
| ▸ | NEU2 | Q9Y3R4 | 8/20 | 0.35 |
| ▸ | NEU3 | Q9UQ49 | 6/20 | 0.35 |
| ▸ | NANP | Q8TBE9 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23640230 | 1.00 | L3MBTL1 (0.50) | L3MBTL1NEU1NEU4NEU2NEU3 | |
| SCHEMBL15081180 | 0.88 | L3MBTL1 (0.49) | L3MBTL1NEU1NEU4NEU2NEU3 | |
| SCHEMBL19960936 | 0.87 | L3MBTL1 (0.48) | L3MBTL1NEU1NEU4NEU2NEU3 | |
| SCHEMBL23591370 | 0.84 | L3MBTL1 (0.38) | L3MBTL1 | |
| SCHEMBL23640384 | 0.83 | NANP (0.53) | L3MBTL1NEU1NEU4NEU2NEU3 | |
| SCHEMBL25518923 | 0.83 | NANP (0.53) | L3MBTL1NEU1NEU4NEU2NEU3 | |
| SCHEMBL20122292 | 0.83 | NANP (0.53) | L3MBTL1NEU1NEU4NEU2NEU3 | |
| SCHEMBL23640226 | 0.82 | L3MBTL1 (0.44) | L3MBTL1NEU1NEU4NEU2NEU3 | |
| SCHEMBL22022487 | 0.81 | L3MBTL1 (0.52) | L3MBTL1NEU1NEU4NEU2NEU3 | |
| SCHEMBL18463735 | 0.81 | L3MBTL1 (0.52) | L3MBTL1NEU1NEU4NEU2NEU3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210198284-A1 | GOLD COMPOSITIONS AND METHODS OF USE THEREOF | UNIVERSITY OF MASSACHUSETTS | 2021-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210198284-A1 | GOLD COMPOSITIONS AND METHODS OF USE THEREOF | LSS, LGALS7; LGALS7B, LGALS3 | L3MBTL1 1291/4885NEU1 348/4885NEU4 213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.